Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oprelvekin effects on cardiac repolarization
NCT00886743Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Sep 2009
- Primary completion
- Dec 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of oprelvekin in Thrombocytopenia, sponsored by Pfizer. Started Sep 2009; status: terminated.
02
Drugs
oprelvekin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00886743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00886743.